Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Pricing: National Academies Weighs In With Some Familiar Proposals

Dec 01 2017

• By Sue Sutter

Dollar sign made with drug pills

Related Content

Drug Pricing Legislation Appears Nowhere In Sight Following Senate Hearing

Oct 18 2017

Orphan Drug Pricing Doesn't Drive Healthcare Costs, NORD Argues

Nov 03 2017

Drug Pricing ‘Opacity,’ Degrees Of Transparency Debated By National Academies Panel

Jan 10 2017

Drug Affordability Review By National Academies Kicks Off With Lower Profile Than Expected

Nov 17 2016

Related Companies

Merck & Co., Inc.

Sanofi Genzyme

Additional Topics

United States Pricing Debate Government Payers Market Access Reimbursement Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window